118 related articles for article (PubMed ID: 36163055)
1. CRABP2 - A novel biomarker for high-risk endometrial cancer.
Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ
Gynecol Oncol; 2022 Nov; 167(2):314-322. PubMed ID: 36163055
[TBL] [Abstract][Full Text] [Related]
2. The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis.
Zeng S; Xu Z; Liang Q; Thakur A; Liu Y; Zhou S; Yan Y
Chem Biol Interact; 2023 Mar; 373():110372. PubMed ID: 36736488
[TBL] [Abstract][Full Text] [Related]
3. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
4. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of retinoic acid sensitivity in pancreatic cancer.
Gupta S; Pramanik D; Mukherjee R; Campbell NR; Elumalai S; de Wilde RF; Hong SM; Goggins MG; De Jesus-Acosta A; Laheru D; Maitra A
Clin Cancer Res; 2012 Jan; 18(1):280-9. PubMed ID: 22010213
[TBL] [Abstract][Full Text] [Related]
6. Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor.
Jiao X; Liu R; Huang J; Lu L; Li Z; Xu L; Li E
Curr Protein Pept Sci; 2020; 21(5):507-516. PubMed ID: 32013828
[TBL] [Abstract][Full Text] [Related]
7. Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas.
Percicote AP; Mardegan GL; Gugelmim ES; Ioshii SO; Kuczynski AP; Nagashima S; de Noronha L
Diagn Pathol; 2018 Jan; 13(1):9. PubMed ID: 29378601
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma In Vivo and In Vitro.
Chen Q; Tan L; Jin Z; Liu Y; Zhang Z
Biomed Res Int; 2020; 2020():3098327. PubMed ID: 32685464
[TBL] [Abstract][Full Text] [Related]
9. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
Piqué DG; Greally JM; Mar JC
BMC Cancer; 2020 Sep; 20(1):857. PubMed ID: 32894083
[TBL] [Abstract][Full Text] [Related]
11. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
12. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
13. Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma.
Liu RZ; Li S; Garcia E; Glubrecht DD; Poon HY; Easaw JC; Godbout R
Glia; 2016 Jun; 64(6):963-76. PubMed ID: 26893190
[TBL] [Abstract][Full Text] [Related]
14. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
Wu Y; Wang J; Ge L; Hu Q
Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
[TBL] [Abstract][Full Text] [Related]
15. A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
Zhang X; Pang X; Huang Y; Qian S
Medicine (Baltimore); 2021 Jul; 100(29):e26648. PubMed ID: 34398021
[TBL] [Abstract][Full Text] [Related]
16. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.
Calmon MF; Rodrigues RV; Kaneto CM; Moura RP; Silva SD; Mota LD; Pinheiro DG; Torres C; de Carvalho AF; Cury PM; Nunes FD; Nishimoto IN; Soares FA; da Silva AM; Kowalski LP; Brentani H; Zanelli CF; Silva WA; Rahal P; Tajara EH; Carraro DM; Camargo AA; Valentini SR
Neoplasia; 2009 Dec; 11(12):1329-39. PubMed ID: 20019841
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
19. CRABP2 and FABP5 expression levels in diseased and normal pancreas.
Hughes CS; ChinAleong JA; Kocher HM
Ann Diagn Pathol; 2020 Aug; 47():151557. PubMed ID: 32593808
[TBL] [Abstract][Full Text] [Related]
20. Cellular retinoic acid-binding protein 2 inhibits tumor growth by two distinct mechanisms.
Vreeland AC; Levi L; Zhang W; Berry DC; Noy N
J Biol Chem; 2014 Dec; 289(49):34065-73. PubMed ID: 25320093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
